Pfizer's and Orbitz's Earnings and Jim Cramer's Stock Pick - Presented by: The Aol. On Network

We're awaiting earnings from Pfizer this morning, which is simultaneously trying to acquire U.K. drugmaker AstraZeneca - in a deal that may cost it much more than the $106 billion it already offered. Orbitz is set to report earnings as well - after under-performing competitors Priceline and Tripadvisor, analysts are forecasting a loss. And Jim Cramer is charged up over one pick he's saying could catch fire in emerging markets.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
AAPL $ 102.25 0.12 ▲ 0.12%
BAC $ 16.01 0.19 ▼ 1.17%
VALE $ 13.11 0.57 ▼ 4.17%
TWTR $ 49.43 1.37 ▲ 2.85%
SIRI $ 3.60 0.01 ▲ 0.28%
PBR $ 19.12 0.09 ▼ 0.47%
FB $ 73.855 0.78 ▼ 1.04%
JCP $ 10.85 0.35 ▼ 3.13%

As of 8/28/2014, 04:03 PM
More Most Active